“…C onsiderable efforts have been devoted to developing new imidazo[1,2-a]pyridine-based heterocycles compounds, 1−4 that is, a single compound that displays the coexistence or synergism of two or more properties including obvious inhibitory effects on many target enzymes 5−7 and good bioactivity in the aspect of antitumor, 8−12 antivirus, 13−15 antibacterial, 16−18 antituberculosis, 19,20 anti-inflammatory, 21 antiulcer, 22 antidiabetic, 23 antipsychotic, 24,25 etc. 3-Substituted imidazo [1,2-a]pyridines are of particular interest, because of their potential applications in many commercially available drugs such as necopidem, alpidem, saripidem, and minodronic acid.…”